InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Wednesday, 07/19/2017 10:48:10 AM

Wednesday, July 19, 2017 10:48:10 AM

Post# of 6401
Big News!

It looks to me the patent worries are over. Brettj your thoughts?

08:28 AM EDT, 07/19/2017 (MT Newswires) -- Bio-Path(BPTH) , developer of anti-cancer treatments, Wednesday reported that the U.S. Patent and Trademark Office has issued a notice of allowance for claims related to the company's proprietary liposomal delivery and antisense technology, including its use in the treatment of cancers, and autoimmune and infectious diseases.

Bio-Path (BPTH) said the new patent, titled "P-Ethoxy Nucleic Acids for Liposomal Formulation," will provide broad protection for application of its proprietary technology in the treatment of a variety of cancers, as well as autoimmune and infectious diseases. The technology is a proprietary liposomal delivery and antisense system, to distribute nucleic acid drugs throughout the body with a simple intravenous transfusion.

Good work by PN on this issue.

Now we can license the antisense delivery system. Ionis are you listening?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News